Central Laboratories Featured Articles

1. Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU 6/4/2025

   Discover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative. 

2. In The Age Of AI, Data Is Still King 5/29/2025

   While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.

3. What's The Risk Of Letting Researchers Use LLMs? 5/21/2025

   Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.

4. How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 5/19/2025

   Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.

5. How Recursion Is Industrializing Clinical Trials With AI 5/12/2025

   Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.

6. Caregiver Distress: The Hidden Burden Of Dementia With Lewy Bodies — And Why Measuring It Matters 5/7/2025

   Taking care of a loved one can be challenging. Cognition Therapeutic experts contend that caregivers’ distress levels must be evaluated to better understand the impact of dementia with Lewy bodies (DLB) on patients, families, and society.

7. Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis 5/5/2025

   Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient.

8. The Evolving Landscape Of Data Integrity In Good Clinical Practice 4/30/2025

   ERA Sciences Andy O'Connor explores the growing focus on data integrity in good clinical practice (GCP) and how regulatory guidance is evolving to support a risk-based, system-life cycle approach.

9. Unsure About The New ICH Guidelines? TransCelerate Debuts 13 Tools To Help 4/23/2025

   TransCelerate BioPharma's Tashan Mistree discusses 13 new tools created alongside the Association of Clinical Research Organizations (ACRO) to support ICH GCP E6(R3) adoption.

10. Data Overload: Determining Which Trial Data To Collect 4/11/2025

    Clinical trials collect a substantial amount of participant data, but not all of it is necessary. Learn how to decide what data's needed and what's not.